Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Filter by Topic

Treatment (remove)
- HIV drugs (remove)
  - Dolutegravir (Tivicay) (remove)
  - Tenofovir (viread) (1)
- Side effects (remove)
Organ and body health (2)
Reproductive and maternal health (1)

Filter by Infection

HIV (remove)

Filter by Resource Category

Research summary (4)

Search results

Current filters: HIV, Treatment, HIV drugs, Side effects, Dolutegravir (Tivicay)

4 search results

Dolutegravir and TAF or TDF—safety issues and weight gain: From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage
Higher levels of dolutegravir in older people not linked to side effects: From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage
Large French study examines neuropsychiatric side effects with integrase inhibitors: From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage
Agencies issue caution about use of dolutegravir by pregnant HIV-positive women: 2018, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.